Literature DB >> 581384

Metrizamide demonstration of the subarachnoid space surrounding the optic nerves.

C Manelfe, U Pasquini, W O Bank.   

Abstract

Intrathecal instillation of metrizamide has provided a useful tool for the in vivo evaluation of smaller structures adjacent to or within the subarachnoid cisterns. The authors report a case in which metrizamide filled the thin subarachnoid space surrounding the optic nerve in its course through the orbit. The finding appears to be infrequent, however, since it was not observed in any instance in a review of 80 metrizamide computed tomographic cisternograms in patients with normal intracranial pressure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581384     DOI: 10.1097/00004728-197811000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  5 in total

1.  The diagnostic value of computed tomography in orbital diseases. A cooperative study of 520 cases.

Authors:  S Wende; E Kazner; T Grumme
Journal:  Neurosurg Rev       Date:  1980       Impact factor: 3.042

2.  Transmural passage of subarachnoid metrizamide into a cystic acoustic schwannoma of the cerebellopontine angle: a diagnostic dilemma.

Authors:  D P Kingsley; A Thornton; C Furneaux; T T King
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

3.  [On the CT-diagnosis of optic nerve lesions. Differential diagnostic criteria (author's transl)].

Authors:  R Unsöld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

4.  Intracranial pressure in patients with the empty sella syndrome without benign intracranial hypertension.

Authors:  A H Kaye; B M Tress; D Brownbill; J King
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

5.  Metrizamide demonstration of the subarachnoid space surrounding the Gasserian ganglion.

Authors:  D Christmann; E Babin
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.